Akebia Therapeutics
AKBA
#6721
Rank
ยฃ0.37 B
Marketcap
ยฃ1.45
Share price
-2.59%
Change (1 day)
22.88%
Change (1 year)

Akebia Therapeutics (AKBA) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ0.20 Billion

According to Akebia Therapeutics's latest financial reports the company's total liabilities are ยฃ0.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Akebia Therapeutics - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.21 B0.61%
2023-12-31ยฃ0.21 B-26.3%
2022-12-31ยฃ0.28 B-14.03%
2021-12-31ยฃ0.33 B15.96%
2020-12-31ยฃ0.29 B1.33%
2019-12-31ยฃ0.28 B1.05%
2018-12-31ยฃ0.28 B58.87%
2017-12-31ยฃ0.17 B-4.93%
2016-12-31ยฃ0.18 B2234.18%
2015-12-31ยฃ8.05 M81.38%
2014-12-31ยฃ4.44 M87.43%
2013-12-31ยฃ2.37 M-22.18%
2012-12-31ยฃ3.04 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ66.17 B 31,754.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.74 B 21,437.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ83.60 B 40,149.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.18 B-9.91%๐Ÿ‡บ๐Ÿ‡ธ USA